IPO Delays Increase in Q3 Amid Market Uncertainty and Rising Yields

In the third quarter of 2026, the trend of companies delaying their initial public offerings is gaining momentum, reflecting broader market challenges rather than isolated corporate issues. Biometric ring maker Oura Health Oy became the latest firm to postpone its IPO, citing uncertain market conditions despite strong investor interest. This move highlights a growing hesitation among companies to go public amid rising bond yields and apprehension about economic factors.

Tom Hale, Oura’s chief executive officer, was seen wearing the company’s signature biometric ring during an interview in San Francisco on June 14, 2024, underscoring the company’s innovative product. However, despite this innovation and reported demand for shares, Oura chose to delay its public debut. Analysts attribute this decision to a more challenging environment for new stock offerings, where market volatility and higher interest rates are weighing on investor enthusiasm.

Matthew Kennedy, a senior strategist at Renaissance Capital, an IPO-focused research firm, pointed out that a series of postponements across different sectors signals systemic issues in the IPO market. "The fact that we've had three or four in a row—a string of postponements—tells you something about the market," Kennedy told CNBC. He emphasized that these delays cannot be chalked up solely to company-specific problems.

In the past week alone, four companies targeting at least $50 million in proceeds have either postponed or withdrawn their IPO plans. This includes Holtec Nuclear, a supplier to the nuclear power industry, which withdrew its IPO last Friday. Materials firm Amaero delayed its offering last Wednesday, and Bamboo Insurance postponed its IPO on September 22. These developments bring the total number of IPO postponements in the third quarter to seven, a rise from four in the second quarter and three in the first quarter.

Jay Ritter, director of the IPO Initiative at the University of Florida's Warrington College of Business, expressed understanding for the companies’ decisions to hold back in the current market. "The fact that three prominent companies are making this move indicates the reasons are not just about individual company issues," Ritter said.

Despite the setbacks, 2026 has seen a relatively strong IPO market overall. Data from Renaissance Capital shows that about $146.9 billion has been raised through 110 IPOs this year, excluding special purpose acquisition companies (SPACs). This total includes large offerings from SpaceX and South Korean memory chip manufacturer SK Hynix during the second quarter. However, these figures represent a 30 percent decrease compared to the same period last year. In 2025, there were 202 IPOs, the highest count since 2021 when nearly 400 companies went public. The increase in total proceeds this year—up nearly 400 percent—is largely driven by a few mega deals, including those from SpaceX, SK Hynix, and chipmaker Cerebras.

Sector-wise, healthcare and industrial companies lead the IPO count this year, each making up 24 percent of the total offerings. Technology firms rank third, accounting for 18 percent. While 59 percent of IPOs in 2026 have maintained or exceeded their initial offering price, the major deals from SpaceX, SK Hynix, and Cerebras have underperformed relative to their IPO price.

Broader economic headwinds are playing a significant role in dampening IPO activity. Renaissance Capital analysts noted in a recent client report that the third quarter saw IPO activity fall short of expectations amid concerns over artificial intelligence spending, bond yields reaching a 19-year high, and the resumption of interest rate hikes. These factors have created a cautious environment for companies considering public listings.

Jay Ritter observed that while there remains enthusiasm for AI-related infrastructure such as data centers, the sector is becoming increasingly commoditized, which could impact investor appetite. Gil Luria, head of technology research at DA Davidson, suggested that Oura’s postponement might be connected to investor wariness toward companies focused on narrow consumer products. He compared Oura to companies like Peloton, GoPro, and Fitbit, which have experienced investor losses in similar niches.

Legal experts note that companies today have more options to raise capital privately, reducing their reliance on the public markets. Ian Schuman, chair of capital markets and public company representation at Latham and Watkins, remarked on the vast and diverse private capital ecosystem available now. He explained that companies not receiving the valuation they seek in the public market can often find alternative financing routes.

As the IPO landscape evolves, firms are weighing the timing and conditions of their public offerings more carefully. The recent wave of postponements reflects a market still adjusting to economic pressures and shifting investor sentiment, indicating that the path to going public in 2026 may be more complex than in previous years.